Department of Pulmonology and Respiratory Medicine

Medicine & Life Sciences

1. Indonesia 100%
2. Tuberculosis 41%
3. Chronic Obstructive Pulmonary Disease 37%
4. Asthma 35%
5. Lung 29%
6. Coronavirus 28%
7. Pulmonary Tuberculosis 22%
8. Lung Neoplasms 19%
9. Multidrug-Resistant Tuberculosis 17%
10. Budesonide 16%
11. Thorax 16%
12. Therapeutics 15%
13. Sputum 12%
14. Pneumonia 12%
15. Cross-Sectional Studies 12%
16. Infections 11%
17. Respiratory Tract Infections 10%
18. Obstructive Sleep Apnea 10%
19. SARS Virus 10%
20. Non-Small Cell Lung Carcinoma 10%
21. Influenza in Birds 10%
22. Smoke 9%
23. Albuterol 9%
24. ErbB Receptors 9%
25. Tobacco Products 9%
26. Pulmonary Aspergillosis 9%
27. Pandemics 8%
28. Smokers 8%
29. Rifampin 8%
30. Pneumoconiosis 8%
31. Mutation 8%
32. Cotinine 7%
33. Quality of Life 7%
34. Inhalation 7%
35. Mortality 7%
36. Artificial Respiration 7%
37. Latent Tuberculosis 7%
38. Respiratory Insufficiency 7%
39. Smoking 7%
40. Formoterol Fumarate 7%
41. Genes 7%
42. Neoplasms 7%
43. OX40 Ligand 7%
44. Isoniazid 7%
45. Pharmaceutical Preparations 7%
46. Bronchodilator Agents 6%
47. Human Influenza 6%
48. Exercise 6%
49. Chemokine CX3CL1 6%
50. Vaccines 6%
51. Occupational Groups 6%
52. Polymerase Chain Reaction 6%
53. Spirometry 6%
54. Routine Diagnostic Tests 6%
55. Costs and Cost Analysis 6%
56. Severe Acute Respiratory Syndrome 6%
57. Placebos 6%
58. Bronchoscopy 6%
59. Fluticasone-Salmeterol Drug Combination 6%
60. Aspergillus 5%
61. Dyspnea 5%
62. Dust 5%
63. Exons 5%
64. Tobacco Use Disorder 5%
65. Health 5%
66. Bronchoalveolar Lavage 5%
67. Randomized Controlled Trials 5%
68. Peak Expiratory Flow Rate 5%
69. Non-Smokers 5%
70. Child 5%
71. Air Pollution 5%
72. Adenocarcinoma of Lung 5%
73. X-Rays 5%
74. Cohort Studies 5%
75. Nebulizers and Vaporizers 5%
76. Intensive Care Units 5%